• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    An apparatus includes detection circuitry and gating circuitry. The detection circuitry is configured to sense a radio frequency (RF) ablation signal that is applied to a heart by an intra-body probe, and to identify time intervals during which an amplitude of an ablation signal is within a predefined window. The gating circuitry is configured to gate an electrocardiogram (ECG) signal acquired in the heart, such that the ECG signal is sampled only within the identified time intervals. t APPLY RF ABLATION SIGNAL TO ABLATION/ECG ELECTRODE DETECT ZERO CROSSINGS OF THE 110 CATHETER SIGNAL VCAT 120 i CATHETER SIGNAL VCAT AT A ZERO NO CROSSING? SAMPLE ECG SIGNAL FROM FIG. 3 130 CATHETER SIGNAL VCAT
    公开号:AU2013206197A1
    申请号:U2013206197
    申请日:2013-06-06
    公开日:2014-01-16
    发明作者:Andres Claudio Altmann；Yaron Ephrath；Assaf Govari
    申请人:Biosense Webster Israel Ltd；
    IPC主号:A61B5-0432
    专利说明:
    1 GATED SAMPLING OF ELECTROCARDIOGRAM SIGNALS DURING ABLATION WAVEFORM ZERO-CROSSING FIELD OF THE INVENTION [0001] The present invention relates generally to cardiac therapy, and particularly to methods and systems for detecting cardiac signals during RF ablation therapy. BACKGROUND OF THE INVENTION [0002] Various techniques are known in the art for isolating between different signals used in cardiac therapy. For example, U.S. Patent Application Publication 2009/0306641, whose disclosure is incorporated herein by reference, describes an array of notch filters for keeping Radio Frequency (RF) ablation energy from penetrating through a pacing circuit. The array comprises two branches of notch filters with high impedance in the frequency range that is used for ablation: one branch protecting the signal path between the pacing circuit and the catheter tip, and the other protecting the return path. The filters have low impedance at the pacing frequency, thus permitting pacing to proceed simultaneously with ablation. [0003] U.S. Patent 7,894,885, whose disclosure is incorporated herein by reference, describes a method for monitoring an electrocardiogram (ECG) signal of a subject. The method includes digitally sampling an average signal from at least a first ECG electrode, determining an average interference frequency, and digitally sampling and buffering a raw ECG signal from at least a second ECG electrode. The method further includes filtering the raw ECG signal to generate a residual signal, calculating, based on the residual signal, a first amplitude and a first phase shift of a primary interference signal at the average interference frequency and a second amplitude and a second phase shift of one or more harmonic interference signals at respective multiples of the average interference frequency, and digitally subtracting the primary interference signal and the harmonic interference signals from the raw ECG signal so as to generate and output a clean ECG signal.
    2 [0004] U.S. Patent 6,647,289, whose disclosure is incorporated herein by reference, describes a cardiorespiratory monitor that generates bioimpedance sensing signals that produce substantially no interference with bioimpedance signals generated by implanted devices. The monitor detects the bioimpedance signal generated by the implanted device. The monitor analyzes this detected signal to generate a bioimpedance sensing signal that will not interfere with the sensed signal. For instance, if the monitor produces a pulsed sensing signal, the pulses are delivered in an interval of the detected signal where no pulses are present. Similarly, if the monitor produces a high frequency AC sensing signal, the zero crossings of the AC sensing signal are positioned during the delivery of a pulse by the implanted device. SUMMARY OF THE INVENTION [0005] An embodiment of the present invention that is described herein provides an apparatus including detection circuitry and gating circuitry. The detection circuitry is configured to sense a radio frequency (RF) ablation signal that is applied to a heart by an intra-body probe, and to identify time intervals during which an amplitude of an ablation signal is within a predefined window. The gating circuitry is configured to gate an electrocardiogram (ECG) signal acquired in the heart, such that the ECG signal is sampled only within the identified time intervals. [0006] In some embodiments, the detection circuitry includes a Schmidt Trigger configured to generate a gating signal when the amplitude of the RF ablation signal is within the predefined window. In other embodiments, the gating circuitry includes an analog-to-digital converter that is gated to sample the electrocardiogram (ECG) signal only during the identified time intervals. [0007] In other embodiments, the apparatus also includes a tunable load for setting the predefined window, such that the Schmidt Trigger is configured to generate the gating signal based on a comparison between the amplitude of the RF ablation signal and a voltage on the tunable load.
    3 [0008] There is also provided, in accordance with an embodiment of the present invention, a method including sensing a radio frequency (RF) ablation signal that is applied to a heart by an intra-body probe. Time intervals are identified during which an amplitude of an ablation signal is within a predefined window. An electrocardiogram (ECG) signal acquired in the heart is gated such that the ECG signal is sampled only within the identified time intervals. [0009] There is also provided, in accordance with an embodiment of the present invention, a cardiac ablation apparatus including a radio frequency (RF) ablation generator, at least one intra-body probe, and a detection and gating unit. The radio frequency (RF) ablation generator is configured to generate an RF ablation signal. The at least one intra body probe is configured to apply the RF ablation signal in a heart and to acquire an electrocardiogram (ECG) signal in the heart. The detection and gating unit further includes detection circuitry and gating circuitry. The detection circuitry is configured to sense the RF ablation signal that is applied by the intra-body probe, and to identify time intervals during which an amplitude of the RF ablation signal is within a predefined window. The gating circuitry is configured to gate the ECG signal acquired in the heart, such that the ECG signal is sampled only within the identified time intervals. [0010] The present invention will be more fully understood from the following detailed description of the embodiments thereof, taken together with the drawings in which: BRIEF DESCRIPTION OF THE DRAWINGS [0011] Fig. 1 is a block diagram that schematically illustrates elements of a catheter ablation system, in accordance with an embodiment of the present invention; [0012] Figs. 2A and 2B are signal diagrams that schematically illustrate generation of an ECG gating signal based on detection of ablation signal zero crossing, in accordance with an embodiment of the present invention; and 4 [0013] Fig. 3 is a flow chart that schematically illustrates a method for simultaneous RF ablation and ECG sensing, in accordance with an embodiment of the present invention. DETAILED DESCRIPTION OF EMBODIMENTS OVERVIEW [0014] Radio frequency catheter ablation (RFCA) is a known technique for the treatment of various cardiac conditions. In this procedure, an intra-body probe, typically a catheter, comprising an ablation electrode at the distal tip is percutaneously inserted into the cardiovascular system and navigated through the cardiovascular system into the heart to the target zone with the damaged tissue to be ablated. An RF signal is applied to the ablation electrode for heating the heart tissue and creating a small non-conducting lesion, which locally removes the parasitic conducting paths of the heart's electrical signals causing tachyarrhythmias and atrial fibrillation. [0015] Monitoring electrocardiogram (ECG) signals while simultaneously applying the RF ablation signal is beneficial for assessing in real time if the procedure improved the heart function, or if more RF ablation needs to be delivered. However, the RF ablation signal itself induces high power, high frequency currents that interfere with the detection of the electrocardiogram signals due to leakage of the RF ablation signal into the detector, which corrupts the ECG signals. [0016] Embodiments of the present invention that are described herein provide improved methods and systems for sensing cardiac ECG signals in the presence of an RF ablation signal. In some embodiments, the RF ablation signal is applied and the ECG signal is received through the use of a common electrode. The ECG signal may be corrupted by leakage of the strong RF signal into the ECG detector. [0017] In the disclosed embodiments, detection circuitry identifies time intervals during which the amplitude of the RF ablation signal is small - Around the zero crossings of the RF ablation signal. Gating circuitry gates the acquisition of the ECG signal, such that the ECG signal is acquired only during the identified time intervals. Since the 5 amplitude of the RF ablation signal is small at these acquisition times, interference from the RF ablation signal to the ECG signal is reduced. [0018] The methods and systems described herein provide an improved detection method of the ECG signals during RF ablation, which eliminates the need for costly high attenuation filters. SYSTEM DESCRIPTION [0019] Fig. 1 is a block diagram that shows elements of a Catheter Ablation System 20, in accordance with an embodiment of the present invention. An example of Catheter Ablation System 20 is described in "Thermocool Irrigated Tip Catheter and Integrated Ablation System," Biosense Webster Inc. (Diamond Bar, California) product brochure, 2006, which is incorporated herein by reference. Alternatively, system 20 may comprise any other suitable system that conducts RF ablation. [0020] Catheter Ablation System 20 comprises an Ablation/ECG Catheter 24. An RF Ablation Generator 28 applies the RF ablation signal an Ablation/ECG Electrode 32 at the distal tip of Ablation/ECG Catheter 24. Ablation/ECG Catheter 24 is navigated into a Heart 36. [0021] When Ablation/ECG Electrode 32 contacts the tissue of the heart and the RF ablation signal is applied, a lesion is formed in the heart tissue as previously described. During the ablation procedure, Ablation/ECG Electrode 32 also senses electrocardiogram signals. In other embodiments not shown in Fig. 1, the Ablation/ECG catheter may comprise a separate electrode for the ECG signal that is offset from the ablation electrode. Further alternatively, the ablation and ECG electrodes may be fitted in separate catheters in heart 36. Nevertheless, coupling or leakage of the RF ablation signal into the ECG electrode would still corrupt the detected ECG signal. [0022] The catheter signal (denoted Vcat in the figure) thus comprises a superposition of both the RF ablation signal and the sensed ECG signal. However, the RF ablation signal is typically considerably stronger than the sensed ECG signal. In one 6 example scenario, the RF ablation signal is on the order of 170V, while the sensed ECG signal is on the order of 70 LV. [0023] In the embodiments of the present invention shown in Fig. 1, Catheter Ablation System 20 also comprises a Zero Crossing Detection/Gating Circuitry 52 comprising a Zero Crossing Sampling Circuit 40 and a Gated Switch 44. The RF ablation signal is sampled by Circuit 40 for detecting the points of the zero-crossing of the RF ablation signal for identifying the time intervals where the instantaneous RF power is small - Within a predefined window. Circuit 40 produces a gating signal used to open or close switch 44. When gated with the gating signal, switch 44 is closed during the identified time intervals and open otherwise. [0024] Within these time intervals, catheter signal Vcat from Ablation/ECG Catheter 24 is then sampled at the zero crossing of the RF ablation signal precisely where the RF ablation signal power is minimal, effectively separating the component of the ECG signal from the RF ablation signal. A clean ECG signal can be then be displayed on an ECG Monitor 48 with little or no additional filtering, in accordance with the embodiments of this invention. [0025] In some embodiments as shown in Fig. 1, Zero Crossing Detection/Gating Circuitry 52 can be implemented by the use of a Schmidt Trigger 56 and an Analog-to Digital (A/D) Converter 60. Catheter signal Vcat enters both Schmidt Trigger 56 and A/D 60. Schmidt Trigger 56 comprises a Tunable Load 64, which is used for setting the predefined window around the ablation signal zero crossing. [0026] The system configuration described in Fig. 1 is chosen purely for sake of conceptual clarity. In alternative embodiments, any other suitable system configuration can be used. For example, detection circuitry 52 is not limited to a Schmidt Trigger and an analog-to-digital converter, and can be implemented by other techniques. [0027] Figs. 2A and 2B are signal diagrams that schematically illustrate generation of the ECG gating signal based on detection of ablation signal zero crossing, in accordance with an embodiment of the present invention. Figs. 2A and 2B show the catheter and 7 gating signal waveforms, respectively, on the same time scale. As shown in Fig. 2A, catheter signal Vcat comprising the RF ablation signal and the negligibly small ECG signal as a function of time t has a respective zero-crossing point within each voltage window AV. [0028] The magnitude of AV is fixed by the value of Tunable Load 64 of Fig. 1. In this implementation, the Schmidt trigger generates the gating signal based on a comparison between Vcat and the voltage on the tunable load. The output of Schmidt trigger 56 as shown in Fig. 2B is a pulse train waveform Vgate, whose pulse width At is determined by the magnitude of AV around the zero crossing point mapped onto the time axis as shown in both Figs. 2A and 2B. [0029] During the pulse width time intervals At, Vgate enables A/D 60 to sample Vcat during the time intervals around the zero crossing of the RF ablation signal component of Vcat allowing a direct sampling of the ECG signal with nearly no corruption by the RF ablation signal. This is shown conceptually in the inset of Fig. 2B. The level of RF leakage is a function of AV, which is controlled by Tunable Load 64. The larger AV, the larger the time interval At which enables the A/D to sample the ECG signals at larger departures away from the zero point crossing of the RF ablation signal, where the instantaneous RF power of the RF ablation signal is higher. [0030] Fig. 3 is a flow chart that schematically illustrates a method for simultaneous RF ablation and ECG sensing, in accordance with an embodiment of the present invention. The method begins with RF Ablation Generator 28 applying an RF Ablation signal to Ablation/ECG Electrode 32 at the distal tip of Ablation/ECG Catheter 24, at an RF ablation step 100. The RF Ablation voltage is the main component of the catheter signal Vcat, which also contains a component of the sensed ECG signal. [0031] At a zero detection step 110, Zero Crossing Sampling Circuit 40 detects the zero crossing of the catheter signal Vcat as shown in Fig. 2A. In other words, circuit 40 identifies the time intervals during which the amplitude of the RF ablation signal is within the predefined window AV.
    8 [0032] At a decision step 120, circuitry 52 checks if catheter signal Vcat passes through a zero crossing, which is the instantaneous level of zero RF Ablation Power. If so, circuit 40 generates a gating signal pulse as shown in Fig 2B. Gating signal Vgate closes Gated Switch 44, and catheter signal Vcat is displayed on ECG Monitor 48 through Gated Switch 44 within the time intervals that Gated Switch 44 is closed, at a sampling step 130. [0033] Although the embodiments described herein mainly address the detection of low level ECG signals at the zero crossings of the large signal RF waveforms used during RF ablation therapy, the methods and systems described herein can also be used in other applications, whereby a small biological signal is detected during the zero crossings of RF energy applied to the body during different medical therapies. [0034] It will thus be appreciated that the embodiments described above are cited by way of example, and that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and sub-combinations of the various features described hereinabove, as well as variations and modifications thereof which would occur to persons skilled in the art upon reading the foregoing description and which are not disclosed in the prior art. Documents incorporated by reference in the present patent application are to be considered an integral part of the application except that to the extent any terms are defined in these incorporated documents in a manner that conflicts with the definitions made explicitly or implicitly in the present specification, only the definitions in the present specification should be considered. [0035] Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps. [0036] The reference to any prior art in this specification is not and should not be taken as an acknowledgement or any form of suggestion that the prior art forms part of the common general knowledge in Australia.
    权利要求:
    Claims (9)
    [1] 1. An apparatus, comprising: detection circuitry, which is configured to sense a radio frequency (RF) ablation signal that is applied to a heart by an intra-body probe, and to identify time intervals during which an amplitude of an ablation signal is within a predefined window; and gating circuitry, which is configured to gate an electrocardiogram (ECG) signal acquired in the heart, such that the ECG signal is sampled only within the identified time intervals.
    [2] 2. The apparatus according to claim 1, wherein the detection circuitry comprises a Schmidt Trigger configured to generate a gating signal when the amplitude of the RF ablation signal is within the predefined window.
    [3] 3. The apparatus according to claim 2, and comprising a tunable load for setting the predefined window, wherein the Schmidt Trigger is configured to generate the gating signal based on a comparison between the amplitude of the RF ablation signal and a voltage on the tunable load.
    [4] 4. The apparatus according to claim 1, wherein the gating circuitry comprises an analog-to-digital converter that is gated to sample the electrocardiogram (ECG) signal only during the identified time intervals.
    [5] 5. A method, comprising: sensing a radio frequency (RF) ablation signal that is applied to a heart by an intra-body probe; identifying time intervals during which an amplitude of an ablation signal is within a predefined window; and gating an electrocardiogram (ECG) signal acquired in the heart, such that the ECG signal is sampled only within the identified time intervals. 10
    [6] 6. The method according to claim 5, wherein gating the ECG signal comprises generating a gating signal using a Schmidt Trigger when the amplitude of the RF ablation signal is within the predefined window.
    [7] 7. The method according to claim 6, and comprising setting the predefined window using a tunable load, wherein generating the gating signal comprises producing the gating signal by the Schmidt Trigger based on a comparison between the amplitude of the RF ablation signal and a voltage on the tunable load.
    [8] 8. The method according to claim 5, wherein gating the ECG signal comprises gating an analog-to-digital converter to sample the ECG signal only during the identified time intervals.
    [9] 9. A cardiac ablation apparatus, comprising: a radio frequency (RF) ablation generator, which is configured to generate an RF ablation signal; at least one intra-body probe for applying the RF ablation signal in a heart and for acquiring an electrocardiogram (ECG) signal in the heart; and a detection and gating unit, comprising: detection circuitry, which is configured to sense the RF ablation signal that is applied by the intra-body probe, and to identify time intervals during which an amplitude of the RF ablation signal is within a predefined window; and gating circuitry, which is configured to gate the ECG signal acquired in the heart, such that the ECG signal is sampled only within the identified time intervals.
    类似技术:
    公开号 | 公开日 | 专利标题
    AU2013206197B2|2017-05-25|Gated sampling of electrocardiogram signals during ablation waveform zero-crossing
    US10143399B2|2018-12-04|Tissue contact sensing with a multi electrode ablation catheter
    US10182742B2|2019-01-22|Tissue contact sensing with a multi electrode ablation catheter
    US8406875B2|2013-03-26|Routing of pacing signals
    CN101601890A|2009-12-16|Be used for pace-making and the wave filter that melts simultaneously
    EP3366207B1|2021-10-06|Highlighting an electrode image according to an electrode signal
    US20170007158A1|2017-01-12|Hemodynamic-signal-based electrode-tissue contact detection
    CN112423667A|2021-02-26|System and method for displaying signals based on signal characteristics
    AU2009230731B2|2015-05-14|Isolation of sensing circuit from pace generator
    WO2008157399A1|2008-12-24|System and method for determining electrode-tissue contact
    EP3610788B1|2022-02-23|Estimation of electrode-tissue contact using oscillator at common ground of electrocardiogram | system
    JP2019537467A|2019-12-26|Filtering device for recording electrophysiological signals
    JP6994027B2|2022-01-14|Filtering device for recording electrophysiological signals
    JP2020005255A|2020-01-09|Signal quality in multiplexing system by actively disconnecting unused connections
    AU2010257392A1|2011-07-07|Measuring weak signals over ablation lines
    El Haddad2014|Signal processing of intracardiac electrograms: optimization of mapping and ablation in tachyarrhythmias
    CA2809454A1|2013-09-21|Automated analysis of complex fractionated electrograms
    同族专利:
    公开号 | 公开日
    IL226746A|2016-06-30|
    CA2818632A1|2013-12-13|
    AU2013206197B2|2017-05-25|
    CN103479347A|2014-01-01|
    EP2674125A1|2013-12-18|
    CN103479347B|2017-08-08|
    US8827993B2|2014-09-09|
    JP6214935B2|2017-10-18|
    IL226746D0|2013-09-30|
    JP2013255803A|2013-12-26|
    EP2674125B1|2014-11-19|
    US20130338520A1|2013-12-19|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US4191188A|1976-05-07|1980-03-04|Macan Engineering & Manufacturing Company, Inc.|Variable crest factor high frequency generator apparatus|
    US5357956A|1992-11-13|1994-10-25|American Cardiac Ablation Co., Inc.|Apparatus and method for monitoring endocardial signal during ablation|
    US6022322A|1998-02-06|2000-02-08|Intermedics Inc.|Non-invasive cardiorespiratory monitor with synchronized bioimpedance sensing|
    JP2007518512A|2004-01-26|2007-07-12|コーニンクレッカフィリップスエレクトロニクスエヌヴィ|Image segmentation for displaying myocardial perfusion|
    CN101401725B|2007-09-27|2013-08-21|西门子公司|Patient treatment using a hybrid imaging system|
    US9204927B2|2009-05-13|2015-12-08|St. Jude Medical, Atrial Fibrillation Division, Inc.|System and method for presenting information representative of lesion formation in tissue during an ablation procedure|
    CN101427284B|2006-04-20|2013-10-02|皇家飞利浦电子股份有限公司|Method of motion correction for dynamic volume alignment without timing restrictions|
    US8920411B2|2006-06-28|2014-12-30|Kardium Inc.|Apparatus and method for intra-cardiac mapping and ablation|
    US7894885B2|2007-05-02|2011-02-22|Biosense Webster, Inc.|Coherent signal rejection in ECG|
    US8357149B2|2008-06-05|2013-01-22|Biosense Webster, Inc.|Filter for simultaneous pacing and ablation|
    US8221411B2|2008-07-28|2012-07-17|Medtronic, Inc.|Systems and methods for cardiac tissue electroporation ablation|US20140276767A1|2013-03-15|2014-09-18|St. Jude Medical, Cardiology Division, Inc.|Ablation system, methods, and controllers|
    US9775663B2|2013-03-15|2017-10-03|St. Jude Medical, Cardiology Division, Inc.|Ablation system, methods, and controllers|
    CN104783894A|2015-04-22|2015-07-22|杭州睿笛生物科技有限公司|Electrocardiogram monitoring and automatic protection device for electrical ablation of tumors|
    CN108601523B|2015-12-17|2021-04-02|德尔格制造股份两合公司|Circuit and method for electrosurgical unit signal detection|
    SG11201900525QA|2016-07-22|2019-02-27|Fisher & Paykel Healthcare Ltd|Sensing for respiratory circuits|
    US10726588B2|2018-10-31|2020-07-28|Biosense WebsterLtd.|Magnetic resonance imagingimage filtration according to different cardiac rhythms|
    CN111728693A|2020-07-06|2020-10-02|白龙腾|System for treating arrhythmia by adopting pulsed electric field ablation technology|
    法律状态:
    2017-09-21| FGA| Letters patent sealed or granted (standard patent)|
    2021-01-07| MK14| Patent ceased section 143(a) (annual fees not paid) or expired|
    优先权:
    申请号 | 申请日 | 专利标题
    US13/495,084|US8827993B2|2012-06-13|2012-06-13|Gated sampling of electrocardiogram signals during ablation waveform zero-crossing|
    US13/495,084||2012-06-13||
    [返回顶部]